Human respiratory viral infections are the leading cause of morbidity and mortality
around the world. Among the various respiratory viruses, coronaviruses (e.g.,
SARS-CoV-2) have created the greatest challenge and most frightening health threat
worldwide. Human coronaviruses typically infect the upper respiratory tract, causing
illnesses that range from common cold-like symptoms to severe acute respiratory
infections. Several promising vaccine formulations have become available since the
beginning of 2021. Nevertheless, achievement of herd immunity is still far from being
realized. Social distancing remains the only effective measure against SARS-CoV-2
infection. Nanobiotechnology enables the design of nanobiosensors. These nanomedical
diagnostic devices have opened new vistas for early detection of viral infections. The
present review outlines recent research on the effectiveness of nanoplatforms as
diagnostic and antiviral tools against coronaviruses. The biological properties of
coronavirus and infected host organs are discussed. The challenges and limitations
encountered in combating SARS-CoV-2 are highlighted. Potential nanodevices such as
nanosensors, nanobased vaccines, and smart nanomedicines are subsequently presented for
combating current and future mutated versions of coronaviruses.